Inhibrx Biosciences, Inc.
Inhibrx Biosciences, Inc. (INBX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · INBX · as of Jun 8, 2026
Key Statistics
Explore Inhibrx Biosciences, Inc. Data
inbx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 60.0%
The INBX analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $325.00, representing +273.52% upside from the current price of $87.01.
Competitors & Peers
inbx competitorsINBX
AMLX
ATAI
CVAC
ELVN
IMTXStock Performance
Full HistoryAbout Inhibrx Biosciences, Inc.
Inhibrx Biosciences, Inc. a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates inclu…
what is inhibrx biosciences, inc. · inbx stock overview · inhibrx biosciences, inc. company profile · who is inhibrx biosciences, inc. ceo · inbx NASDAQ · inhibrx biosciences, inc. headquarters · inhibrx biosciences, inc. business segments
About Stock Overview & Key Data
Inhibrx Biosciences, Inc. (INBX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 4, 2024. As of the latest trading session, INBX stock price is $87.01, with a market capitalization of $1.3B. The stock has returned +504.66% over the past 12 months and +10.14% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Inhibrx Biosciences, Inc. stock is Buy, with an average 12-month price target of $325.00. In fiscal year 2025, Inhibrx Biosciences, Inc. reported revenue of $1.3M and net income of -$140.1M. For detailed data — including Inhibrx Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Inhibrx Biosciences, Inc. (INBX) stock price is $87.01. The stock is traded on NASDAQ under the ticker symbol INBX. The 52-week range is $12.80 – $155.29.